Progestin plus metformin improves outcomes in patients with endometrial hyperplasia and early endometrial cancer more than progestin alone: a meta-analysis

OBJECTIVE: Progestin based therapy is the preferred option for fertility-sparing treatment of reproductive-age women with preserved fertility in endometrial hyperplasia (EH) or early endometrial cancer (EEC). Our objective was to investigate whether metformin could enhance the efficacy of progestin-...

Descripción completa

Detalles Bibliográficos
Autores principales: Shao, Fengping, Li, Yinguang, Zhao, Yunhe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10320576/
https://www.ncbi.nlm.nih.gov/pubmed/37415671
http://dx.doi.org/10.3389/fendo.2023.1139858

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10320576/
https://www.ncbi.nlm.nih.gov/pubmed/37415671
http://dx.doi.org/10.3389/fendo.2023.1139858

Ejemplares similares